Kidney cancer clinical practice guidelines in oncology

Robert J. Motzer, Graeme B. Bolger, Barry Boston, Michael A. Carducci, Mayer Fishman, Steven L. Hancock, Ralph J. Hauke, Gary R. Hudes, Eric Jonasch, Philip Kantoff, Timothy M. Kuzel, Paul H. Lange, Ellis G. Levine, Chris Logothetis, Kim A. Margolin, Kamal Pohar, Bruce G. Redman, Cary N. Robertson, Wolfram E. Samlowski, Joel Sheinfeld

Research output: Contribution to journalArticlepeer-review

Abstract

An estimated 38,890 Americans will be diagnosed with kidney cancer and 12,840 will die of this disease in the United States in 2006. Renal cell carcinoma (RCC) constitutes approximately 2% of all malignancies, with a median age at diagnosis of 65 years. Smoking and obesity are among the risk factors for RCC development, and tumor grade, local extent of the tumor, presence of regional nodal metastases, and evidence of metastatic disease at presentation are the most important prognostic determinants of 5-year survival. These guidelines discuss evaluation, staging, treatment, and management after treatment.

Original languageEnglish (US)
Pages (from-to)1072-1081
Number of pages10
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume4
Issue number10
DOIs
StatePublished - Nov 2006
Externally publishedYes

Keywords

  • Clear cell tumors
  • Kidney disease
  • NCCN Clinical Practice Guidelines
  • Nephrectomy
  • Renal cell carcinoma

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Kidney cancer clinical practice guidelines in oncology'. Together they form a unique fingerprint.

Cite this